FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio Chella

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Antonio Marchetti; Felice Mucilli; Carmela Pullara; Patrizia Viola; Antonio Chella; Lara Felicioni; Maria Grazia Sciarrotta; Luigi Guetti; Sara Malatesta; Fiamma Buttitta
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.
Alfonso Cristaudo; Nicolino Ambrosino; Alessandra Bonotti; Antonio Chella; Giovanni Guglielmi; Marco Lucchi; Alfredo Mussi; Silvia Simonini; Agnese Vivaldi; Rudy Foddis
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma.
Antonio Chella; Massimo Cossentino; Valeria Seidita
Self-conscious robotic system design process--from analysis to implementation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio Chella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Antonio Marchetti; Felice Mucilli; Carmela Pullara; Patrizia Viola; Antonio Chella; Lara Felicioni; Maria Grazia Sciarrotta; Luigi Guetti; Sara Malatesta; Fiamma Buttitta
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(26):3574-9.
2011: Alfonso Cristaudo; Nicolino Ambrosino; Alessandra Bonotti; Antonio Chella; Giovanni Guglielmi; Marco Lucchi; Alfredo Mussi; Silvia Simonini; Agnese Vivaldi; Rudy Foddis
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1587-93.
2011: Antonio Chella; Massimo Cossentino; Valeria Seidita
Self-conscious robotic system design process--from analysis to implementation.
Advances in experimental medicine and biology 2011;718():209-21.
2010: Alfonso Cristaudo; Rudy Foddis; Alessandra Bonotti; Silvia Simonini; Agnese Vivaldi; Giovanni Guglielmi; Nicolino Ambrosino; Pier Aldo Canessa; Antonio Chella; Marco Lucchi; Alfredo Mussi; Luciano Mutti
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma.
The International journal of biological markers 2010;25(3):164-70.
2010: Antonio Chella
A robot architecture based on higher order perception loop.
Advances in experimental medicine and biology 2010;657():267-83.
2008: Antonio Chella; Marcello Frixione; Salvatore Gaglio
A cognitive architecture for robot self-consciousness.
Artificial intelligence in medicine 2008;44(2):147-54.
2008: Enrico Vasile; Carmelo Tibaldi; Antonio Chella; Alfredo Falcone
Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(8):912-4.
2008: Antonio Marchetti; Lara Felicioni; Giuseppe Pelosi; Maela Del Grammastro; Caterina Fumagalli; Mariagrazia Sciarrotta; Sara Malatesta; Antonio Chella; Fabio Barassi; Felice Mucilli; Pierpaolo Camplese; Tommaso D'Antuono; Rocco Sacco; Fiamma Buttitta
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.
Human mutation 2008;29(5):609-16.
2007: Alfonso Cristaudo; Rudy Foddis; Agnese Vivaldi; Giovanni Guglielmi; Nicola Dipalma; Rosangela Filiberti; Monica Neri; Marcello Ceppi; Michela Paganuzzi; Gian Paolo Ivaldi; Manlio Mencoboni; Pier Aldo Canessa; Nicolino Ambrosino; Antonio Chella; Luciano Mutti; riccardo puntoni
Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5076-81.
2007: Rudy Foddis; Agnese Vivaldi; Rosangela Filiberti; riccardo puntoni; Luciano Mutti; Nicolino Ambrosino; Antonio Chella; Giovanni Guglielmi; Vittorio Gattini; Rodolfo Buselli; S Perretta; Alfonso Cristaudo
[Serum mesothelin dosages in follow-up of previously exposed workers].
Giornale italiano di medicina del lavoro ed ergonomia 2007;29(3 Suppl):342-5.
2007: Marco Lucchi; Antonio Chella; Franca Melfi; Paolo Dini; Carmelo Tibaldi; Gabriella Fontanini; Alfredo Mussi
Four-modality therapy in malignant pleural mesothelioma: a phase II study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(3):237-42.
2007: Marco Lucchi; Antonio Chella; Franca Melfi; Paolo Dini; Marcello Carlo Ambrogi; Leonardo Fino; Gabriella Fontanini; Alfredo Mussi
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2007;31(3):529-33; discussion 533-4.
2006: Fiamma Buttitta; Fabio Barassi; Giuseppina Fresu; Lara Felicioni; Antonio Chella; Diego Paolizzi; Giuseppe Lattanzio; Simona Salvatore; Pierpaolo Camplese; Sandra Rosini; Teodorico Iarussi; Felice Mucilli; Rocco Sacco; Andrea Mezzetti; Antonio Marchetti
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features.
International journal of cancer. Journal international du cancer 2006;119(11):2586-91.
2006: Carmelo Tibaldi; Ilaria Bernardini; Antonio Chella; Francesa Russo; Enrico Vasile; Michele Malventi; Alfredo Falcone
Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer.
Clinical lung cancer 2006;7(6):401-5.
2006: Riccardo Rizzo; Antonio Chella
A comparison between habituation and conscience mechanism in self-organizing maps.
IEEE transactions on neural networks / a publication of the IEEE Neural Networks Council 2006;17(3):807-10.
2006: Alessandro Ribechini; Valeria Bottici; Antonio Chella; Rossella Elisei; P Vitti; Aldo Pinchera; N Ambrosino
Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer.
Journal of endocrinological investigation 2006;29(2):131-5.
2006: Adriano Paccagnella; Francesco Oniga; alessandra bearz; ADOLFO FAVARETTO; Maurizia Clerici; Fausto Barbieri; Alberto Riccardi; Antonio Chella; Umberto Tirelli; Giovanni Luca Ceresoli; Salvatore Tumolo; Ruggero Ridolfi; Rita Biason; Maria Ornella Nicoletto; Paolo Belloni; Fabrizio Veglia; Maria Grazia Ghi
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):681-7.
2006: Carmelo Tibaldi; Ilaria Bernardini; Antonio Chella; Francesa Russo; G Toma; F Tempestini; M Malventi; E Vasile; N Ambrosino; Alfredo Falcone
Prolonged gemcitabine infusion in advanced non-small-cell lung cancer with stable disease after gemcitabine 30-min infusion.
Lung cancer (Amsterdam, Netherlands) 2006;51(2):217-23.
2005: Fiamma Buttitta; Carla Martella; Fabio Barassi; Lara Felicioni; Simona Salvatore; Sandra Rosini; Tommaso D'Antuono; Antonio Chella; Felice Mucilli; Rocco Sacco; Andrea Mezzetti; Franco Cuccurullo; Robert Callahan; Antonio Marchetti
Int6 expression can predict survival in early-stage non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3198-204.
2005: Antonio Marchetti; Carla Martella; Lara Felicioni; Fabio Barassi; Simona Salvatore; Antonio Chella; Pierpaolo Camplese; Teodorico Iarussi; Felice Mucilli; Andrea Mezzetti; Franco Cuccurullo; Rocco Sacco; Fiamma Buttitta
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):857-65.
2004: Antonio Marchetti; Fabio Barassi; Carla Martella; Antonio Chella; Simona Salvatore; Antonio Castrataro; Felice Mucilli; Rocco Sacco; Fiamma Buttitta
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1338-43.
2003: Romano Danesi; Antonella Lupetti; Cecilia Barbara; Emilia Ghelardi; Antonio Chella; Tecla Malizia; Sonia Senesi; Carlo Alberto Angeletti; Mario Del Tacca; Mario Campa
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg.
The Journal of antimicrobial chemotherapy 2003;51(4):939-45.
2003: Franca Melfi; Antonio Chella; Gian Franco Menconi; Francesco Givigliano; Giuseppe Boni; Giuliano Mariani; Paolo Sbragia; Carlo Alberto Angeletti
Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2003;23(2):214-20.
2002: Antonello Di Paolo; Cecilia Barbara; Antonio Chella; Carlo Alberto Angeletti; Mario Del Tacca
Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;46(6):545-50.
2002: Antonio Marchetti; Caterina Pellegrini; Fiamma Buttitta; Monica Falleni; Solange Romagnoli; Lara Felicioni; Fabio Barassi; Simona Salvatore; Antonio Chella; Carlo Alberto Angeletti; Massimo Roncalli; Guido Coggi; Silvano Bosari
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Laboratory investigation; a journal of technical methods and pathology 2002;82(6):729-36.
2002: Antonio Marchetti; Nicola Tinari; Fiamma Buttitta; Antonio Chella; Carlo Alberto Angeletti; Rocco Sacco; Felice Mucilli; Axel Ullrich; Stefano Iacobelli
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.
Cancer research 2002;62(9):2535-9.
2002: Franca Melfi; Gian Franco Menconi; Antonio Chella; Carlo Alberto Angeletti
The management of malignant pericardial effusions using permanently implanted devices.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2002;21(2):345-7.
2000: Giuseppe Boni; CR Bellina; Mariano Grosso; Marco Lucchi; Gianpiero Manca; Marcello Carlo Ambrogi; Duccio Volterrani; Gian Franco Menconi; Franca Melfi; Alessandro Gonfiotti; Federico Davini; Carlo Alberto Angeletti; R Bianchi; Antonio Chella
Gamma probe-guided thoracoscopic surgery of small pulmonary nodules.
Tumori 2000;86(4):364-6.
2000: Antonio Chella; Marco Lucchi; Marcello Carlo Ambrogi; Gian Franco Menconi; Franca Melfi; Alessandro Gonfiotti; Giuseppe Boni; Carlo Alberto Angeletti
A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2000;18(1):17-21.
2000: Antonio Chella; Marcello Carlo Ambrogi; Alessandro Ribechini; Alfredo Mussi; M G Fabrini; Giovanni Silvano; Luca Cionini; Carlo Alberto Angeletti
Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study.
Lung cancer (Amsterdam, Netherlands) 2000;27(3):169-75.
1999: Antonio Marchetti; Gloria Bertacca; Fiamma Buttitta; Antonio Chella; G Quattrocolo; Carlo Alberto Angeletti; Generoso Bevilacqua
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2077-81.
1998: Antonio Marchetti; S Pellegrini; Gabriella Sozzi; Gloria Bertacca; P Gaeta; Fiamma Buttitta; Vittoria Carnicelli; P Griseri; Antonio Chella; Carlo Alberto Angeletti; Marco A Pierotti; Generoso Bevilacqua
Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
British journal of cancer 1998;78(1):73-8.
1998: Antonio Marchetti; S Pellegrini; Gloria Bertacca; Fiamma Buttitta; P Gaeta; Vittoria Carnicelli; Vincenzo Nardini; P Griseri; Antonio Chella; Carlo Alberto Angeletti; Generoso Bevilacqua
FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
The Journal of pathology 1998;184(3):240-6.
1998: Antonio Marchetti; C Doglioni; Mattia Barbareschi; Fiamma Buttitta; S Pellegrini; P Gaeta; R La Rocca; GR Merlo; Antonio Chella; Carlo Alberto Angeletti; Paolo Dalla Palma; Generoso Bevilacqua
Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer.
International journal of cancer. Journal international du cancer 1998;75(2):187-92.
1997: Marco Lucchi; Alfredo Mussi; Antonio Chella; Alberto Janni; Alessandro Ribechini; Gian Franco Menconi; Carlo Alberto Angeletti
Surgery in the management of small cell lung cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1997;12(5):689-93.
1997: Gabriella Sozzi; L Sard; L De Gregorio; Antonio Marchetti; K Musso; Fiamma Buttitta; S Tornielli; S Pellegrini; Maria L Veronese; Giacomo Manenti; Matteo Incarbone; Antonio Chella; Carlo Alberto Angeletti; Ugo Pastorino; Kay Huebner; G Bevilaqua; Silvana Pilotti; Carlo M Croce; Marco A Pierotti
Association between cigarette smoking and FHIT gene alterations in lung cancer.
Cancer research 1997;57(11):2121-3.
1997: Antonio Marchetti; Fiamma Buttitta; S Pellegrini; Gloria Bertacca; Antonio Chella; Vittoria Carnicelli; V Tognoni; A Filardo; Carlo Alberto Angeletti; Generoso Bevilacqua
Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
The Journal of pathology 1997;181(2):178-82.
1996: Editta Baldini; Carmelo Tibaldi; Antonio Chella; Carlo Alberto Angeletti; Giovanni Silvano; A Andrei; R Algeri; Pier Franco Conte
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(7):747-9.
1996: Carlo Alberto Angeletti; Marco Lucchi; Gabriella Fontanini; Alfredo Mussi; Antonio Chella; Alessandro Ribechini; S Vignati; Generoso Bevilacqua
Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
Cancer 1996;78(3):409-15.
1996: Antonio Marchetti; Fiamma Buttitta; S Pellegrini; Antonio Chella; Gloria Bertacca; A Filardo; V Tognoni; F Ferreli; E Signorini; Carlo Alberto Angeletti; Generoso Bevilacqua
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
The Journal of pathology 1996;179(3):254-9.
1996: Alfredo Mussi; Massimo Pistolesi; Marco Lucchi; Alberto Janni; Antonio Chella; G Parenti; Giuseppe Rossi; Carlo Alberto Angeletti
Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors.
The Journal of thoracic and cardiovascular surgery 1996;112(1):146-53.
1996: Antonio Marchetti; Claudio Doglioni; Mattia Barbareschi; Fiamma Buttitta; S Pellegrini; Gloria Bertacca; Antonio Chella; GR Merlo; Carlo Alberto Angeletti; Paolo Dalla Palma; Generoso Bevilacqua
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
Oncogene 1996;12(6):1319-24.
1995: Antonio Chella; Marco Lucchi; F Gragnani; Alessandro Ribechini; Giovanni Silvano; Alberto Janni; Alfredo Mussi; Carlo Alberto Angeletti
[The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung].
Minerva chirurgica 1995;50(12):1029-38.
1995: Antonio Chella; Marco Lucchi; Alessandro Ribechini; Giovanni Silvano; Alfredo Mussi; Alberto Janni; Carlo Alberto Angeletti
Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):393-7.
1995: Antonio Marchetti; Fiamma Buttitta; S Pellegrini; GR Merlo; Antonio Chella; Carlo Alberto Angeletti; Generoso Bevilacqua
mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1995;4(2):93-7.
1995: Carlo Alberto Angeletti; Alfredo Mussi; Alberto Janni; Marco Lucchi; Alessandro Ribechini; Antonio Chella; Gabriella Fontanini
Second primary lung cancer and relapse: treatment and follow-up.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1995;9(11):607-11.
1994: Alfredo Mussi; Antonio Chella; P Magistrelli; Alessandro Ribechini; Marco Lucchi; P Dini; Carlo Alberto Angeletti
[The diagnosis of primary lesions of the anterior mediastinum].
Minerva chirurgica 1994;49(12):1257-62.
1994: Antonio Chella; Alessandro Ribechini; P Dini; C Adamo; Alfredo Mussi; Carlo Alberto Angeletti
[Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Minerva chirurgica 1994;49(11):1077-82.
1994: Editta Baldini; Carmelo Tibaldi; Antonio Chella; Carlo Alberto Angeletti; A Romanini; A Andrei; R Algeri; Giovanni Silvano; Pier Franco Conte
Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
Seminars in oncology 1994;21(3 Suppl 4):12-5.
1993: Antonio Marchetti; Fiamma Buttitta; GR Merlo; F Diella; S Pellegrini; Stefano Pepe; P Macchiarini; Antonio Chella; Carlo Alberto Angeletti; Robert Callahan
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.
Cancer research 1993;53(12):2846-51.
1991: P Macchiarini; Antonio Chella; Francesca Ducci; B Rossi; Cesarina Testi; Generoso Bevilacqua; Carlo Alberto Angeletti
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma.
Cancer 1991;68(4):706-13.
1991: P Macchiarini; Giovanni Silvano; Alberto Janni; Alfredo Mussi; Antonio Chella; Carlo Alberto Angeletti
Results of treatment and lessons learned from pathologically staged T4 non-small cell lung cancer.
Journal of surgical oncology 1991;47(4):209-14.
1991: P Macchiarini; M Hardin; Fulvio Basolo; J Bruno; Antonio Chella; Carlo Alberto Angeletti
Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer. Rationale for current approach.
American journal of clinical oncology 1991;14(3):218-24.
1990: P Bagnolesi; Anna Cilotti; M Bimbi; Carlo Bartolozzi; Antonio Chella; Alfredo Mussi; P Dini
[Computerized tomography in post-operative recurrence of bronchial carcinoma].
La Radiologia medica 1990;80(6):853-8.
1990: P Macchiarini; Antonio Chella; A Riva; Giovanna Mengozzi; Giovanni Silvano; S Solfanelli; Carlo Alberto Angeletti
Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer.
American journal of clinical oncology 1990;13(6):495-500.